Repercussions of raloxifen, tamoxifen and estrogen on aortic atherosclerotic lesions of female rabbits submitted to ovariectomy and hypercholesterol diet

Maturitas

Volumn 50, Issue 1, 2005, Pages 30-38

  Kallás Hueb, Cristina ^a   Mendes Aldrighi, José ^a   Kallás, Elias ^a   Franchini Ramires, José Antonio ^a  

^a SP CEP 05409 011 ^*  (Brazil)

Author keywords

Atherosclerosis; Cholesterol; Hormones; Lipids; Plaque

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; RALOXIFENE; TAMOXIFEN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOMATION; BLOOD VESSEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HYPERCHOLESTEROLEMIA; NONHUMAN; OVARIECTOMY; POSTOPERATIVE PERIOD; RABBIT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; THORACIC AORTA;

ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MODELS, ANIMAL; OVARIECTOMY; PHOTOGRAPHY; PROSPECTIVE STUDIES; RABBITS; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TRIGLYCERIDES;

ANIMALIA; EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 10044226103     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.03.012     Document Type: Article

References (30)

1. Mathews K.A., Meilahn E., Kuller L.H., et al. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 321:1989;641-646
2. Campos H., McNamara J.R., Wilson P.W., et al. Differences in low density lipoprotein sub-fractions and apolipoproteins in pre menopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 67:1988;30-35
3. Haarbo J., Svendsen O.L., Christiansen C. Progestogens do not effect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ. Res. 70:1992;1198-1202
4. Consensus development conference: prophylaxis and treatment of osteoporosis, Am J Med 1991;90:107-10.
5. Herrington D.M., Klein K.P. Cardiovascular trials of estrogen replacement therapy. Ann. NY Acad. Sci. 949:2001;153-162
6. Rossouw J.E. Debate: the potential role of estrogen in the prevention of heart disease in women after menopause. Curr. Control. Trials Cardiovasc. Med. 1(3):2000;135-138
7. Walsh B.W., Kuller L.H., Wild R.A., et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. J. Am. Med. Assoc. 279:1998;1445-1451
8. Love R.R., Mazess R.B., Borden H.S., et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med. 326:1992;852-856
9. McDonald C.C., Stewart H.J. Fatal myocardial infarction in the scottish adjuvant tamoxifen trial. Br. Med. J. 303:1991;435-437
10. Rutqvist L.E., Mattsson A. Cardiac and thromboembolic morbidity among postmenopausal women with early breast cancer in a randomized trial of adjuvant tamoxifen. J. Nat. Cancer Inst. 85:1993;1398-1406
11. Barret-Connor E., Wenger N.K., Grady D., et al. Coronary heart disease in women randomized clinical trials, HERS and RUTH. Maturitas. 31:1998;1-7
12. Bjarnason N.H., Haarbo J., Bryalsen J., et al. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation. 96:1997;1964-1969
13. Lowry O.H., Rosebrough N.J., Farr A.L., et al. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275
14. Hollander M, Wolfe DA. Nonparametric statistical methods. Wiley, 1973.
15. Timm NH. Multivariate analysis with applications in education and psychology. Monterey, CA: Brooks/Cole; 1975.
16. Bjarnason N.H., Haarbo J., Byrjalsen I., et al. Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits. Clin. Endocrinol. 52(2):2000;225-233
17. Bjarnason N.H., Haarbo J., Byrjalsen I., et al. Raloxifene and estrogen reduces progression of advanced atherosclerosis- a study in ovariectomized, cholesterol-fed rabbits. Atherosclerosis. 154(1):2001;97-102
18. Castelo-Branco C., Sanjuan A., Casals E. Raloxifene inhibits cholesterol aortic content but not atherosclerotic plaque size in oophorectomised cholesterol-fed rabbits. J. Obstet. Gynaecol. 24(1):2004;47-51
19. Bjarnason N.H., Haarbo J., Byrjalsen I., et al. Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomised, cholesterol-fed rabbits. Clin. Endocrinol. 52:2000;225-233
20. Black L.J., Jones C.D., Falcone J.F. Antagonism of estrogen action with a new benzothiophene derived antiestrogen. Life Sci. 32:1983;1031-1036
21. Webb P., Lopez G.N., Uht R.M., et al. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456
22. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J. Am. Med. Assoc. 280:1998;605-613
23. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. J. Am. Med. Assoc. 288:2002;49-57
24. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. J Am Med Assoc 2002;288;321-33.
25. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. J. Am. Med. Assoc. 289:2003;3243-3253
26. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. J. Am. Med. Assoc. 289:2003;2673-2684
27. Cushman M., Constantino J.P., Tracy R.P., et al. Tamoxifen and cardiac risk factors in healthy women: Suggestions of an anti-inflammatory effect. Arterioscler. Thromb. Vasc. Biol. 21(2):2001;255-261
28. Reis S.E., Constantino J.P., Wickerham D.L., et al. Cardiovascular effects of tamoxifen in women with and without heart disease. J. Nat. Cancer Inst. 93(1):2001;16-21
29. Mosca L., Barrett-Connor E., Wenger N.K., et al. Design and methods of the raloxifene use for the heart (RUTH) study. Am. J. Cardiol. 88(4):2001;392-395
30. Barret-Connor E., Grady D., Sashegyi A., et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. J. Am. Med. Assoc. 287:2002;847-857